Clinalytic seems to be a platform or technology aimed at using artificial intelligence for clinical decision support in healthcare. Such systems often leverage AI algorithms to analyze medical data, assist healthcare professionals in diagnosing conditions, determining treatment plans, predicting outcomes, and optimizing patient care.

The range of Artificial Intelligence for Clinical Decision Support, Clinalytix, was unveiled for the first time in France at the press conference of the national event the D4 Evolution.

It is a fully integrated AI solution that, using structured and unstructured data in the DPI, can identify and predict the occurrence of adverse events by generating an alert whenever necessary.

The first two cases of use will focus on sepsis and dementia, through pilot projects “set up in the 1strimestre 2021 and put into practice in the second half of the year,” said Emmanuel Mougeotte, head of Dedalus HealthCare France.

The first establishments to benefit from routine Clinalytix will be those using Dedalus DPI, for a planned deployment in 2022.